Upload Prescription

Category: Medicines

Gifaxin 100 mg Syrup

Gifaxin 100 mg Syrup is an antibiotic medicine containing Rifaximin, used to treat bacterial infections of the intestine. Unlike many antibiotics, Rifaximin acts mainly in the gut and is poorly absorbed into the bloodstream, which makes it especially useful for gastrointestinal infections.

It is commonly prescribed for children and adults who require a liquid formulation, particularly in cases of traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy (liver-related brain complications).

Uses / Indications

  • Traveler’s diarrhea caused by non-invasive strains of E. coli

  • Irritable bowel syndrome with diarrhea (IBS-D)

  • Hepatic encephalopathy (to reduce recurrence by lowering toxin-producing bacteria)

  • Intestinal bacterial overgrowth

  • Other bacterial gut infections as prescribed

How It Works (Mechanism of Action)

  • Rifaximin (100 mg/5 ml):

    • A rifamycin antibiotic that works by blocking bacterial RNA synthesis.

    • Prevents bacteria from multiplying and eliminates harmful gut bacteria.

    • Since it is minimally absorbed into the bloodstream, it acts directly in the intestine, reducing side effects and systemic exposure.

Dosage & Administration

  • Dose depends on age, weight, and condition being treated.

  • Typically given two to three times daily for a set duration (as prescribed).

  • Shake the bottle well before each use.

  • Can be taken with or without food.

  • Complete the full course, even if symptoms improve, to prevent antibiotic resistance.

Side Effects

Common:

  • Nausea, vomiting, abdominal pain

  • Flatulence (gas), bloating

  • Headache, dizziness

  • Fever in children

  • Constipation or loose stools

Rare but serious:

  • Severe allergic reactions (rash, swelling, breathing difficulty)

  • Bloody stools, severe diarrhea (may indicate Clostridium difficile infection)

  • Liver function disturbances in long-term use

Precautions & Warnings

  • Not effective for invasive bacterial infections (like those causing high fever or bloody diarrhea).

  • Use with caution in patients with liver disease.

  • Not recommended for children under 2 years unless prescribed.

  • May interact with certain medicines (e.g., warfarin, cyclosporine).

  • Pregnancy and breastfeeding: use only if clearly advised by a doctor.

  • Long-term use may lead to antibiotic resistance.

Summary

Gifaxin 100 mg Syrup (Rifaximin 100 mg/5 ml) is a gut-targeted antibiotic used for traveler’s diarrhea, IBS-D, hepatic encephalopathy, and bacterial gut infections. It works locally in the intestine with minimal systemic absorption, making it safer than many antibiotics. While effective, it can cause nausea, bloating, dizziness, or rare allergic reactions, so it should be taken only under medical supervision.

Gifaxin 200 Tablet

Gifaxin 200 Tablet contains Rifaximin, a broad-spectrum, gut-specific antibiotic mainly used for treating intestinal infections. Unlike most antibiotics, Rifaximin works locally in the intestine because it is minimally absorbed into the bloodstream. This makes it particularly useful in conditions related to bacterial overgrowth in the gut.

Uses / Indications

  • Traveler’s diarrhea caused by non-invasive Escherichia coli

  • Irritable Bowel Syndrome with Diarrhea (IBS-D)

  • Hepatic encephalopathy (prevents recurrence by lowering gut ammonia-producing bacteria)

  • Small intestinal bacterial overgrowth (SIBO)

  • Other intestinal infections as advised by the doctor

How It Works (Mechanism of Action)

  • Rifaximin (200 mg): Belongs to the rifamycin class of antibiotics.

  • Blocks bacterial RNA synthesis → stops bacterial growth and multiplication.

  • Works locally in the gut, targeting harmful bacteria while sparing beneficial ones to some extent.

Dosage & Administration

  • Typical adult dose: 200 mg tablet 2–3 times daily (varies depending on condition).

  • Swallow with water, with or without food.

  • Duration of treatment usually ranges from 3 to 14 days depending on diagnosis.

  • Complete the full prescribed course even if symptoms improve early.

(Exact dosage should always be confirmed by a doctor.)

Side Effects

Common:

  • Nausea, vomiting

  • Abdominal pain, bloating, gas

  • Headache, dizziness

  • Fatigue

Less common but possible:

  • Constipation or diarrhea

  • Skin rash or itching

  • Fever

Serious (rare):

  • Severe allergic reaction (swelling, breathing difficulty, rash)

  • Severe or persistent diarrhea (possible Clostridium difficile infection)

  • Liver-related side effects in long-term/high-dose use

Precautions & Warnings

  • Not useful for infections with fever, blood in stool, or systemic bacterial infections.

  • Caution in patients with severe liver disease.

  • Prolonged use may lead to antibiotic resistance.

  • Safety in pregnancy and breastfeeding is not fully established – use only if clearly prescribed.

  • Inform the doctor about all ongoing medicines (possible interactions with cyclosporine, warfarin, etc.).

Summary

Gifaxin 200 Tablet (Rifaximin 200 mg) is a gut-targeted antibiotic mainly prescribed for traveler’s diarrhea, IBS-D, hepatic encephalopathy, and bacterial intestinal infections. It is generally safe with mild side effects like nausea, bloating, or headache, but must be taken only under medical guidance to avoid resistance or complications.

Gifaxin 400 Tablet

Gifaxin 400 Tablet contains Rifaximin (400 mg), a non-absorbable, broad-spectrum antibiotic. It acts primarily within the intestine and is not significantly absorbed into the bloodstream, which makes it safer compared to systemic antibiotics. It is prescribed for traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), hepatic encephalopathy, and certain bacterial intestinal infections.

Uses / Indications

  • Traveler’s diarrhea (caused by non-invasive E. coli)

  • Irritable Bowel Syndrome with Diarrhea (IBS-D) – reduces bloating and stool frequency

  • Hepatic encephalopathy – lowers the risk of recurrence by reducing ammonia-producing bacteria

  • Small intestinal bacterial overgrowth (SIBO)

  • Intestinal infections caused by susceptible bacteria

How It Works (Mechanism of Action)

  • Rifaximin (400 mg): Blocks bacterial RNA synthesis, preventing growth and multiplication.

  • Acts locally in the gastrointestinal tract, with minimal absorption → fewer systemic side effects.

  • Helps restore gut balance by targeting harmful bacteria while sparing some beneficial flora.

Dosage & Administration

  • Typical adult dose: 400 mg 2–3 times daily (depends on condition).

  • Taken orally with or without food.

  • Treatment duration varies:

    • Traveler’s diarrhea – usually 3 days

    • IBS-D – may be prescribed for 10–14 days

    • Hepatic encephalopathy – often long-term therapy as per doctor’s advice

  • Always complete the full prescribed course.

(Dosage should always be confirmed by a doctor depending on the condition and patient profile.)

Side Effects

Common:

  • Nausea, abdominal discomfort

  • Flatulence, bloating, constipation or diarrhea

  • Headache, dizziness

  • Fatigue

Less common:

  • Rash, itching

  • Muscle pain or joint pain

Serious (rare):

  • Severe diarrhea (possible Clostridium difficile infection)

  • Allergic reactions (swelling of face/lips, difficulty in breathing)

  • Liver-related side effects with prolonged use

Precautions & Warnings

  • Not effective against systemic infections or diarrhea with blood/fever.

  • Use with caution in severe liver impairment.

  • Long-term use may lead to antibiotic resistance.

  • Safety in pregnancy and breastfeeding not well established – use only if prescribed.

  • Inform your doctor about any other medicines (e.g., cyclosporine, anticoagulants).

Summary

Gifaxin 400 Tablet (Rifaximin 400 mg) is a gut-specific antibiotic mainly prescribed for IBS-D, hepatic encephalopathy, traveler’s diarrhea, and intestinal bacterial overgrowth. It is effective and generally safe with mild digestive or neurological side effects, but must be taken under strict medical supervision to avoid resistance and complications.

Glemont-A Tablet SR

Glemont-A Tablet SR is a combination medication formulated to manage respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).

  • Acebrophylline (200mg): A bronchodilator that relaxes the muscles of the airways, making breathing easier. It also has mucolytic properties, helping to clear mucus from the lungs.

  • Montelukast (10mg): A leukotriene receptor antagonist that reduces airway inflammation and prevents asthma attacks or allergic reactions.

This combination provides both symptomatic relief from bronchoconstriction and long-term protection against airway inflammation, improving overall lung function and reducing the frequency of asthma episodes.

Uses

  • Management of bronchial asthma (both acute and chronic)

  • Treatment of allergic rhinitis with respiratory symptoms

  • Relief from chronic obstructive pulmonary disease (COPD) symptoms

  • Prevention of exercise-induced bronchoconstriction

  • Helps reduce wheezing, coughing, and shortness of breath

Dosage & Directions for Use

  • Adult dose: 1 tablet once daily, preferably in the evening

  • Swallow the tablet whole with water; do not crush or chew

  • Can be taken with or without food

  • Dose adjustment may be required for patients with liver or kidney impairment

  • Should be taken regularly for best preventive effect, not only during attacks

Possible Side Effects

Common:

  • Headache

  • Mild stomach upset or nausea

  • Dizziness

  • Fatigue

Less common but serious:

  • Allergic reactions (rash, swelling, itching)

  • Mood changes or sleep disturbances (rare with montelukast)

  • Palpitations or irregular heartbeat

  • Worsening of liver function in susceptible individuals

Glemont-F Tablet

Glemont-F Tablet is an effective anti-allergic medicine that combines two active ingredients – Montelukast and Fexofenadine. It is widely used in the treatment of allergic rhinitis, hay fever, asthma (as supportive therapy), and chronic urticaria (skin hives and itching). By blocking the action of both histamine and leukotrienes, it provides fast, long-lasting relief from symptoms like sneezing, runny or blocked nose, watery eyes, nasal congestion, skin rashes, and itching.

This dual-action formula makes it a preferred choice for patients who suffer from repeated or seasonal allergies.

Uses of Glemont-F Tablet

  • Relief from seasonal allergies (hay fever)

  • Management of perennial allergic rhinitis (allergies throughout the year)

  • Treatment of chronic urticaria (hives, swelling, itching of skin)

  • Supportive therapy in asthma to prevent wheezing and breathing difficulty

  • Reduces symptoms like sneezing, watery/itchy eyes, blocked nose, runny nose, and skin irritation

How Glemont-F Tablet Works

  • Montelukast (10mg): A leukotriene receptor antagonist that blocks certain natural substances (leukotrienes) responsible for airway inflammation, swelling, and bronchospasm. It helps in improving breathing and reducing nasal congestion.

  • Fexofenadine (120mg): A non-sedating antihistamine that blocks histamine action, preventing allergy symptoms like itching, sneezing, watery eyes, and skin irritation.

Together, they provide comprehensive relief from allergy symptoms.

When and How to Use

  • Take the tablet once daily, preferably in the evening or as advised by your doctor.

  • Can be taken with or without food; however, taking it with water is recommended.

  • Do not skip doses, and do not stop suddenly without consulting your doctor.

Side Effects of Glemont-F Tablet

Most side effects are mild and temporary:

  • Headache

  • Nausea or stomach discomfort

  • Dry mouth

  • Tiredness or dizziness

  • Flu-like symptoms (rare)

  • Skin rash (rare)

Seek immediate medical help if you notice mood changes, breathing difficulty, or severe allergic reactions.

Precautions & Warnings

  • Pregnancy & Breastfeeding: Use only under medical advice.

  • Liver/Kidney Patients: Dose adjustment may be required; consult your doctor.

  • Children & Elderly: Should be used under strict medical supervision.

  • Avoid alcohol as it can increase drowsiness and reduce alertness.

  • Do not drive or operate heavy machinery if you feel dizzy or sleepy.

  • Inform your doctor if you are taking other medicines for seizures, antibiotics, antifungals, or heart conditions, as drug interactions are possible.

Conclusion

Glemont-F Tablet is a powerful combination therapy that addresses both respiratory and skin-related allergic conditions. By targeting two major allergy pathways, it provides better symptom control than single-agent medicines. Regular use as prescribed by a doctor can significantly improve breathing, reduce nasal congestion, control sneezing, and prevent uncomfortable skin rashes or itching. It is especially beneficial for patients dealing with persistent or seasonal allergies that affect sleep, work, and overall quality of life.

Always follow your doctor’s guidance for safe and effective use.

GLIMDA 1

GLIMDA 1 Tablet is an oral antidiabetic (sulfonylurea class) prescribed for the management of type 2 diabetes mellitus when diet and exercise are insufficient to control blood sugar levels. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose. Ongoing glycemic management with this medication—along with a balanced diet and physical activity—helps to reduce the risks of diabetes complications such as kidney damage, eye problems, and nerve issues.

Key Benefits:

  • Lowers raised blood sugar levels in type 2 diabetes patients

  • Helps prevent diabetes-related complications (kidney, eye, nerve)

  • Supports long-term blood glucose management when lifestyle measures are not enough

Directions for Use:

  • Take once daily with or just after the first main meal

  • Swallow whole with water; do not chew or crush

  • Always follow your doctor’s instructions regarding dose and schedule

Side Effects:
May include nausea, dizziness, headache, weight gain, and hypoglycemia (low blood sugar). Symptoms of hypoglycemia include sweating, shakiness, dizziness, and hunger.

Safety Advice:

  • Use with caution in patients with liver or kidney issues

  • Not for those with type 1 diabetes or diabetic ketoacidosis

  • Avoid alcohol; can increase risk of hypoglycemia

  • Pregnant or breastfeeding women should use only if clearly needed, with doctor’s advice

  • Regularly monitor blood sugar

Storage:
Store in a cool, dry place below 30°C, away from moisture and sunlight, and out of reach of children.

GLIMEPIRIDE 1mg Tablet

Company: (Available as generics; most commonly by Cipla Ltd under brands like GLIMDA 1, or as Amaryl by other companies)

Composition:

  • Glimepiride 1 mg

Description:
Glimepiride 1mg tablets are used for the treatment of type 2 diabetes mellitus. As a sulfonylurea, it lowers blood sugar by increasing insulin secretion from the pancreas and improving the body’s response to insulin. It is effective when diet, exercise, and weight control alone are insufficient and may also be used in combination with other antidiabetic medications or insulin.

Key Benefits:

  • Lowers fasting and post-meal blood sugar in type 2 diabetes

  • Reduces risk of developing complications from diabetes

  • Can be used alone or with other antidiabetic agents

Directions for Use:

  • Take once daily, usually with breakfast or the first meal of the day

  • Take at the same time every day for best effect

  • Do not miss or double doses; follow your doctor’s instructions

Side Effects:
Common side effects include low blood sugar (hypoglycemia), headache, nausea, weakness, dizziness, and weight gain. Know signs of hypoglycemia; keep a sugar source available.

Safety Advice:

  • Avoid in type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease

  • Notify your doctor of any pre-existing conditions or medications

  • Caution with alcohol; increases risk of low blood sugar

  • Monitor blood sugar regularly; doctor may require periodic lab tests

  • Avoid during pregnancy or breastfeeding unless prescribed

Storage:
Store below 30°C, in a cool, dry place, away from direct sunlight and children.

GLIMDA 1 TABLET

GLIMDA 1 Tablet is an antidiabetic medicine from Cipla Ltd, containing Glimepiride (1mg). It belongs to the class of sulfonylureas and is prescribed to manage type 2 diabetes mellitus in adults. The medicine helps in reducing high blood sugar levels when lifestyle changes like diet and exercise alone are not enough.

Glimepiride works by stimulating the pancreas to release more insulin and by improving the body’s response to it. This dual action helps lower blood glucose levels effectively and reduces the risk of diabetes-related complications such as nerve damage, kidney disease, and vision problems.

Key Benefits:

  • Controls blood sugar levels in type 2 diabetes.

  • Can be prescribed alone or in combination with other antidiabetic medicines.

  • Helps prevent long-term complications of uncontrolled diabetes.

Usage & Dosage:

  • Usually taken once daily, preferably before or with breakfast.

  • The exact dosage depends on the patient’s condition and blood sugar levels, as directed by the doctor.

  • Consistent use along with proper diet and physical activity gives maximum benefit.

Safety Advice:

  • Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.

  • May cause hypoglycemia if meals are missed, or after heavy exercise or alcohol intake.

  • Dose adjustment may be required in patients with liver or kidney problems.

  • Regular blood sugar monitoring is important during treatment.

Possible Side Effects:

  • Low blood sugar (sweating, dizziness, hunger, shakiness)

  • Headache

  • Nausea or upset stomach

  • Weight gain in some individuals

GLIMDA 2

Glimda 2 Tablet is an oral anti-diabetic medication manufactured by Cipla Ltd, containing Glimepiride 2mg as its active ingredient. It belongs to the class of sulfonylureas (insulin secretagogues) and is mainly used in the management of type 2 diabetes mellitus when diet, exercise, and lifestyle measures alone are insufficient to control blood sugar levels.

How it Works:
Glimepiride stimulates the beta cells in the pancreas to release more insulin by blocking ATP-sensitive potassium channels, which leads to increased insulin secretion. The released insulin helps lower blood glucose by promoting cellular uptake and utilization of glucose, as well as suppressing glucose production by the liver. Glimepiride is only effective in individuals whose bodies still produce insulin naturally and is not suitable for type 1 diabetes or diabetic ketoacidosis.

Uses of Glimda 2:

  • Treatment of type 2 diabetes mellitus

  • Reduces the risk of diabetes-related complications such as kidney damage, nerve issues, and vision loss when blood sugar is controlled

Key Benefits:

  • Effectively lowers both fasting and postprandial (after-meal) blood sugar

  • Can be used alone or in combination with other oral anti-diabetic agents or insulin

  • Helps prevent long-term complications of poorly controlled diabetes

Dosage & Administration:

  • Usual dosage: One tablet once daily, taken with breakfast or the first main meal

  • Dose may be adjusted by your physician based on blood sugar response

  • Should be taken regularly at the same time every day for best results

  • Do not stop or change the dose without consulting your doctor

Safety & Precautions:

  • To be used only under medical supervision

  • Patients with kidney or liver impairment, the elderly, and those with a history of low blood sugar (hypoglycemia) should use with caution

  • Common side effects include hypoglycemia (low blood sugar), dizziness, headache, nausea, and weight gain

  • Alcohol should be avoided, as it can further lower blood sugar or increase side effects

  • Not recommended in pregnancy and breastfeeding unless prescribed by a doctor

Note: Blood glucose should be monitored regularly while taking Glimda 2 Tablet, and compliance with lifestyle advice remains essential for optimal diabetes control.

GLIMDA 3 TAB

Glimda 3 Tablet is an oral anti-diabetic medicine manufactured by Cipla Ltd, containing Glimepiride 3mg as its active ingredient. It belongs to the sulfonylurea class of drugs and is primarily used for the management of type 2 diabetes mellitus in adults, particularly when lifestyle changes (diet and exercise) alone are inadequate for blood sugar control.

How it Works:
Glimepiride lowers blood sugar by stimulating the pancreas to release more insulin. It acts on pancreatic beta cells, resulting in increased insulin secretion, which enables the body’s cells to absorb and utilize glucose more efficiently. This mechanism effectively lowers elevated blood glucose and helps prevent long-term complications of diabetes such as kidney disease, nerve damage, and vision loss.

Uses of Glimda 3:

  • Management of type 2 diabetes mellitus

  • Reducing the risk of diabetes-related complications with effective blood sugar control

Key Benefits:

  • Provides effective control of both fasting and postprandial (after-meal) blood glucose

  • Can be used alone or in combination with other oral anti-diabetic agents or insulin

  • Contributes to prevention of serious diabetes complications when used long-term

Dosage & Administration:

  • Usual dosage: One tablet daily, typically with or just before the first main meal

  • Dose adjustments may be made by your physician based on blood glucose response

  • Take the tablet whole with water, at the same time each day for maximum benefit

  • Do not stop or change dose without consulting your doctor

Safety & Precautions:

  • To be taken only under medical supervision

  • Not to be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease

  • Caution in the elderly, and in those with a history of low blood sugar (hypoglycemia)

  • Common side effects: hypoglycemia (low blood sugar), dizziness, headache, nausea, weakness, weight gain

  • Alcohol should be avoided, as it can increase the risk of low blood sugar

  • Blood glucose levels should be monitored regularly while on Glimda 3

  • Not recommended in pregnancy and breastfeeding unless specifically prescribed

Note:
Consistent blood sugar monitoring, regular follow-ups, adherence to prescribed diet and exercise, and taking Glimda 3 Tablet exactly as directed are critical for optimal diabetes management and prevention of complications.

GLIMDA-MV 1

Glimda-MV 1 Tablet is a fixed-dose combination anti-diabetic medicine from Cipla Ltd, containing Metformin Hydrochloride 500mg, Glimepiride 1mg, and Voglibose 0.2mg per tablet. It is specially formulated for the management of type 2 diabetes mellitus in adults, especially when lifestyle changes or single-drug therapy does not provide adequate blood sugar control.

How it Works:

  • Metformin lowers blood sugar by reducing glucose production in the liver, enhancing the body’s response to insulin, and decreasing glucose absorption from the intestines.

  • Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, aiding glucose uptake by cells.

  • Voglibose is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestines, thereby preventing sharp increases in blood glucose after meals (postprandial spikes).

The combination of these three medicines targets different mechanisms in diabetes, resulting in more robust and sustained glycemic control and lowering the risk of complications such as nerve damage, kidney problems, and heart disease.

Uses of Glimda-MV 1:

  • Management of type 2 diabetes mellitus

  • Control of fasting and postprandial blood glucose

  • Prevention of long-term diabetes complications in adults

Key Benefits:

  • Provides effective, multi-faceted blood sugar control

  • Reduces the need for multiple separate diabetes pills

  • Prevents sharp rises in blood sugar after meals

  • Decreases risk of diabetes-related complications

  • May help with weight management in some patients

Dosage & Administration:

  • Usual dosage: One tablet daily (frequency and timing as directed by doctor), with meals to minimize gastrointestinal side effects

  • Swallow whole with water; do not crush or chew

  • Follow diet and exercise recommendations strictly for best results

  • Take at the same time each day for consistent effectiveness

Safety & Precautions:

  • Use only under medical guidance

  • Patients with kidney or liver disease, elderly, or with a history of low blood sugar, should use with caution

  • Common side effects: hypoglycemia (if meals are missed or delayed), nausea, stomach pain, diarrhea, dizziness, headache

  • Take with meals to reduce gastrointestinal upset

  • Monitor blood sugar regularly during treatment

  • Not for use in type 1 diabetes, diabetic ketoacidosis, or severe renal/hepatic impairment

  • Avoid alcohol during therapy as it increases the risk of side effects

Note:
Do not stop or change the dose on your own. Always carry a sugar source for hypoglycemia, and inform your healthcare provider about all other medicines you use.

GLIMDA-MV 1 Tablet SR

GLIMDA-MV 1 Tablet is a triple combination antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg), which work together to effectively control type 2 diabetes mellitus in adults.

  • Glimepiride (1mg): A sulfonylurea that stimulates the pancreas to release insulin.

  • Metformin (500mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity.

  • Voglibose (0.2mg): An alpha-glucosidase inhibitor that slows down carbohydrate absorption from the intestine, preventing sudden spikes in blood sugar after meals.

This powerful combination targets different mechanisms of diabetes, offering better glycemic control compared to single-drug therapy.

Key Benefits:

  • Provides comprehensive control of blood sugar levels in type 2 diabetes.

  • Reduces fasting as well as post-meal blood sugar spikes.

  • Helps lower the risk of diabetes-related complications like neuropathy, nephropathy, and retinopathy.

  • Useful in patients who do not achieve sufficient control with single or dual therapy.

Usage & Dosage:

  • Taken orally, usually once or twice daily with meals to avoid stomach upset.

  • Dosage depends on individual blood sugar levels and doctor’s advice.

  • Should be continued along with proper diet and exercise.

Safety Advice:

  • Not suitable for type 1 diabetes or diabetic ketoacidosis.

  • Risk of hypoglycemia may occur, especially if meals are skipped or excessive exercise is done.

  • Should be avoided in patients with severe kidney or liver problems.

  • Alcohol should be avoided, as it may increase the risk of lactic acidosis with metformin.

  • Regular monitoring of blood sugar and HbA1c is recommended.

Possible Side Effects:

  • Low blood sugar (sweating, hunger, dizziness)

  • Stomach pain, bloating, diarrhea

  • Nausea, metallic taste (due to metformin)

  • Mild weight gain in some patients

GLIMDA-MV 2

Glimda-MV 2 Tablet is a fixed-dose combination anti-diabetic medicine from Cipla Ltd that contains Metformin Hydrochloride 500mg, Glimepiride 2mg, and Voglibose 0.2mg per tablet. This triple combination is prescribed for the management of type 2 diabetes mellitus in adults, especially when single or dual therapy does not adequately control blood sugar.

How it Works:

  • Metformin: Reduces glucose production in the liver, delays glucose absorption from the intestines, and improves the body’s response to insulin.

  • Glimepiride: A sulfonylurea that increases the secretion of insulin from the pancreas, helping cells absorb and use glucose.

  • Voglibose: Delays the breakdown and absorption of carbohydrates in the intestine, preventing sharp blood sugar spikes after meals (postprandial glucose control).

By targeting different aspects of glucose control, Glimda-MV 2 provides strong management of both fasting and postprandial blood glucose levels, helping to prevent diabetes-related complications such as kidney damage, retinopathy, neuropathy, and cardiovascular risks.

Uses of Glimda-MV 2:

  • Management of type 2 diabetes mellitus in adults

  • Control of fasting and post-meal blood glucose levels

  • Reduces risk of long-term diabetes complications

Key Benefits:

  • Triple action—targets sugar production, utilization, and absorption

  • Prevents severe post-meal glucose spikes

  • Simplifies diabetes therapy by combining three drugs into one tablet

  • Prevents sudden rises in blood glucose

  • May assist with weight management and improve overall metabolic health

Dosage & Administration:

  • Usual dosage: One tablet daily (specific dosing frequency as advised by your doctor), typically taken with meals to minimize stomach upset

  • Swallow whole with water; do not crush or chew

  • Take at the same time each day for consistent efficacy

  • Continue diet and exercise recommendations for best results

Safety & Precautions:

  • Use only on medical prescription

  • Monitor blood sugar levels regularly during treatment

  • Common side effects: hypoglycemia (especially if meals are missed), nausea, vomiting, stomach pain, diarrhea, dizziness, headache

  • Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease

  • Avoid alcohol during therapy to reduce the risk of side effects

  • Dose adjustments may be needed in patients with kidney or liver impairment

  • Not to be discontinued abruptly without consulting your doctor

Note:
Consistent monitoring, adherence to diet and exercise, and regular follow-ups are crucial for safe and effective diabetes management with Glimda-MV 2 Tablet.